Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia in the BFORE trial: 24-month follow-up Meeting Abstract
| Authors: | Cortes, J. E.; Mauro, M. J.; Deininger, M. W. N.; Chuah, C.; Kim, D. W.; Kota, V.; Lipton, J. H.; Rousselot, P. H.; Milojkovic, D.; Le Coutre, P. D.; Gutierrez, V. G.; Crescenzo, R. J.; Leip, E.; An, F.; Bouxin, N.; Hochhaus, A.; Brümmendorf, T. H.; Gambacorti-Passerini, C. |
| Abstract Title: | Bosutinib vs imatinib for newly diagnosed chronic myeloid leukemia in the BFORE trial: 24-month follow-up |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 379s |
| Language: | English |
| ACCESSION: | WOS:000442916002501 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.7002 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7002 -- Source: Wos |
